Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: A cost-effectiveness analysis

Digestive Diseases and Sciences

Volumn 55, Issue 3, 2010, Pages 852-860

  Huang, Edward S ^a,b   Gazelle, G Scott ^a,b,c   Hur, Chin ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Branch duct IPMN; Consensus guidelines; Cost effectiveness; IPMN; Malignancy; Pancreatic cysts; Surgery

Indexed keywords

ARTICLE; CANCER MORTALITY; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DISEASE SURVEILLANCE; EMERGENCY SURGERY; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALIGNANT TRANSFORMATION; MEDICAL DECISION MAKING; PANCREAS CANCER; PANCREAS SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME; ADULT; AGED; COLLOID CARCINOMA; COST BENEFIT ANALYSIS; INTRADUCTAL CARCINOMA; MIDDLE AGED; PANCREAS TUMOR; PAPILLARY CARCINOMA; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, PAPILLARY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; MIDDLE AGED; PANCREATIC NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 77949332616     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1014-y     Document Type: Article

References (51)

1. B Taouli V Vilgrain D O'Toole, et al. 2002 Intraductal papillary mucinous tumors of the pancreas: features with multimodality imaging J Comput Assist Tomogr 26 223 231 10.1097/00004728-200203000-00011 11884778 (Pubitemid 34233369)
2. M Kobari S Egawa K Shibuya, et al. 1999 Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management Arch Surg 134 1131 1136 10.1001/archsurg.134.10.1131 1:STN:280:DyaK1MvltVKqtw%3D%3D 10522860 (Pubitemid 29473205)
3. B Terris P Ponsot F Paye, et al. 2000 Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct Am J Surg Pathol 24 1372 1377 10.1097/00000478-200010000-00006 1:STN:280:DC%2BD3cvmvVagtw%3D%3D 11023098
4. R Doi K Fujimoto M Wada, et al. 2002 Surgical management of intraductal papillary mucinous tumor of the pancreas Surgery 132 80 85 10.1067/msy.2002. 125386 12110799 (Pubitemid 34787825)
5. T Matsumoto M Aramaki K Yada, et al. 2003 Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas J Clin Gastroenterol 36 261 265 10.1097/00004836-200303000-00014 12590239 (Pubitemid 36232639)
6. BS Choi TK Kim AY Kim, et al. 2003 Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography Korean J Radiol 4 157 162 10.3348/kjr.2003.4.3.157 14530644
7. Y Kitagawa TA Unger S Taylor, et al. 2003 Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas J Gastrointest Surg 7 12 18 10.1016/S1091-255X(02)00152-X 12559180 discussion 18-19 (Pubitemid 36875796)
8. M Sugiyama Y Izumisato N Abe, et al. 2003 Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas Br J Surg 90 1244 1249 10.1002/bjs.4265 1:STN:280:DC%2BD3svltl2htg%3D%3D 14515294 (Pubitemid 37330429)
9. TA Sohn CJ Yeo JL Cameron, et al. 2004 Intraductal papillary mucinous neoplasms of the pancreas: an updated experience Ann Surg 239 788 797 10.1097/01.sla.0000128306.90650.aa 15166958 discussion 797-799 (Pubitemid 38669430)
10. R Salvia C Fernandez-del Castillo C Bassi, et al. 2004 Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection Ann Surg 239 678 685 10.1097/01.sla.0000124386.54496.15 15082972 discussion 685-687 (Pubitemid 38525639)
11. ST Chari D Yadav TC Smyrk, et al. 2002 Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas Gastroenterology 123 1500 1507 10.1053/gast.2002.36552 12404225 (Pubitemid 35231650)
12. M Niedergethmann R Grutzmann R Hildenbrand, et al. 2008 Outcome of Invasive and Noninvasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas (IPMN): a 10-year experience World J Surg 32 2253 2260 10.1007/s00268-008-9692-8 18668283
13. K Nagai R Doi A Kida, et al. 2008 Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection World J Surg 32 271 278 10.1007/s00268-007-9281-2 18027021 discussion 279-280
14. JY Jang SW Kim SE Lee, et al. 2008 Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 15 199 205 10.1245/s10434-007-9603-5 17909912
15. M Tanaka S Chari V Adsay, et al. 2006 International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 17 32 10.1159/000090023 16327281
16. H Irie K Yoshimitsu H Aibe, et al. 2004 Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography J Comput Assist Tomogr 28 117 122 10.1097/00004728-200401000-00020 14716244 (Pubitemid 38057866)
17. PE Rautou P Levy MP Vullierme, et al. 2008 Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study Clin Gastroenterol Hepatol 6 807 814 10.1016/j.cgh.2007.12.021 18304885
18. G Kobayashi N Fujita Y Noda, et al. 2005 Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS J Gastroenterol 40 744 751 10.1007/s00535-005-1619-7 16082592 (Pubitemid 41349087)
19. S Tanno Y Nakano T Nishikawa, et al. 2008 Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results Gut 57 339 343 10.1136/gut.2007.129684 1:STN:280:DC%2BD1c7gs1yiug%3D%3D 17660227 (Pubitemid 351288099)
20. P Levy V Jouannaud D O'Toole, et al. 2006 Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy Clin Gastroenterol Hepatol 4 460 468 10.1016/j.cgh.2006.01.018 16616351
21. R Salvia S Crippa M Falconi, et al. 2007 Branch-duct intraductal papillary mucinous neoplasms of the pancreas: To operate or not to operate? Gut 56 1086 1090 10.1136/gut.2006.100628 17127707 (Pubitemid 47123238)
22. JR Rodriguez R Salvia S Crippa, et al. 2007 Branch-duct intraductal papillary mucinous neoplasms: Observations in 145 patients who underwent resection Gastroenterology 133 72 79 10.1053/j.gastro.2007.05.010 17631133 quiz 309-310 (Pubitemid 47031144)
23. RS Tang B Weinberg DW Dawson, et al. 2008 Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm Clin Gastroenterol Hepatol 6 815 819 10.1016/j.cgh.2008.04.005 18602036 quiz 719 (Pubitemid 351888940)
24. M Pelaez-Luna ST Chari TC Smyrk, et al. 2007 Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients Am J Gastroenterol 102 1759 1764 10.1111/j.1572-0241.2007.01224.x 17686073 (Pubitemid 47206677)
25. M Pelaez-Luna N Takahashi JG Fletcher, et al. 2007 Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis Am J Gastroenterol 102 2157 2163 10.1111/j.1572-0241.2007.01480.x 17897335 (Pubitemid 47493852)
26. M Sugiyama Y Atomi 1998 Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies Ann Surg 228 685 691 10.1097/00000658-199811000-00008 1:STN:280:DyaK1M%2FkvFGmsQ%3D%3D 9833807 (Pubitemid 30198313)
27. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press; 2006.
28. JE Siegel MC Weinstein LB Russell, et al. 1996 Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine JAMA 276 1339 1341 10.1001/jama.276.16.1339 1:STN:280: DyaK2s%2FhsFWltA%3D%3D 8861994 (Pubitemid 26346934)
29. American Medical Association. Current Procedural Terminology Book. 2008.
30. HCUP Nationwide Inpatient Sample (NIS). Volume 2008. Rockville, MD: Agency For Healthcare Research and Quality, 2008.
31. Income, Poverty, and Health Insurance Coverage in the United States. Volume 2008: U.S. Census Bureau, 2007.
32. K Turaga M Kaushik RA Forse, et al. 2008 In hospital outcomes after pancreatectomies: an analysis of a national database from 1996 to 2004 J Surg Oncol 98 156 160 10.1002/jso.21099 18618606
33. MK Diener HP Knaebel C Heukaufer, et al. 2007 A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma Ann Surg 245 187 200 10.1097/01.sla.0000242711.74502.a9 17245171 (Pubitemid 46148477)
34. Economic costs of diabetes in the U.S. In 2007. Diabetes Care 2008;31:596-615.
35. KR Yabroff EB Lamont A Mariotto, et al. 2008 Cost of care for elderly cancer patients in the United States J Natl Cancer Inst 100 630 641 10.1093/jnci/djn103 18445825
36. TJ Howard JW Jones S Sherman, et al. 2001 Impact of pancreatic head resection on direct medical costs in patients with chronic pancreatitis Ann Surg 234 661 667 10.1097/00000658-200111000-00012 1:STN:280:DC%2BD3MngvFyktQ%3D%3D 11685030 (Pubitemid 33048802)
37. J Hanmer WF Lawrence JP Anderson, et al. 2006 Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores Med Decis Making 26 391 400 10.1177/0272989X06290497 16855127 (Pubitemid 44050843)
38. SJ Warnick Jr V Velanovich 2006 Correlation of patient-derived utility values and quality of life after pancreaticoduodenectomy for pancreatic cancer J Am Coll Surg 202 906 911 10.1016/j.jamcollsurg.2006.02.032 16735204 (Pubitemid 43776436)
39. C Hur NS Nishioka GS Gazelle 2004 Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus J Natl Cancer Inst 96 316 325 1:CAS:528:DC%2BD2cXhsV2qtb8%3D 14970280 (Pubitemid 38256276)
40. SL Bowker SL Pohar JA Johnson 2006 A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer Health Qual Life Outcomes 4 17 10.1186/1477-7525-4-17 16553957
41. AS Pickard MP Neary D Cella 2007 Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer Health Qual Life Outcomes 5 70 10.1186/1477-7525-5-70 18154669 (Pubitemid 351298228)
42. TA Sohn CJ Yeo JL Cameron, et al. 1998 Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg 2 207 216 10.1016/S1091-255X(98) 80014-0 1:STN:280:DyaK1M%2FlvF2lsA%3D%3D 9841976
43. M Pignone S Saha T Hoerger, et al. 2002 Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 137 96 104 12118964 (Pubitemid 34779153)
44. J Mandelblatt S Saha S Teutsch, et al. 2003 The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 139 835 842 14623621
45. D Provenzale J Lipscomb 1996 Cost-effectiveness: definitions and use in the gastroenterology literature Am J Gastroenterol 91 1488 1493 1:STN:280:DyaK28zit1WmtQ%3D%3D 8759647 (Pubitemid 26269156)
46. C Fernandez-del Castillo J Targarona SP Thayer, et al. 2003 Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients Arch Surg 138 3 427 discussion 433-434 (Pubitemid 36417680)
47. Diener MK, Heukaufer C, Schwarzer G, et al. Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev. 2008:CD006053. (Pubitemid 351807394)
48. JT McPhee JS Hill GF Whalen, et al. 2007 Perioperative mortality for pancreatectomy: a national perspective Ann Surg 246 246 253 10.1097/01.sla. 0000259993.17350.3a 17667503 (Pubitemid 47196522)
49. M Sho Y Nakajima H Kanehiro, et al. 1998 Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas World J Surg 22 874 878 10.1007/s002689900485 1:STN:280:DyaK1czjvVemsg%3D%3D 9673562 (Pubitemid 28322087)
50. T Schnelldorfer MG Sarr DM Nagorney, et al. 2008 Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas Arch Surg 143 639 646 10.1001/archsurg.143.7.639 18645105 discussion 646 (Pubitemid 352040228)
51. CP Raut KR Cleary GA Staerkel, et al. 2006 Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival Ann Surg Oncol 13 582 594 10.1245/ASO.2006.05.002 16523362